GLENMEDE TRUST CO NA - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 177 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$469,000
+35.9%
12,575
-6.9%
0.00%0.0%
Q1 2021$345,000
+18.6%
13,513
+1.7%
0.00%0.0%
Q4 2020$291,000
+35.3%
13,290
+10.8%
0.00%
+100.0%
Q3 2020$215,000
-6.5%
11,990
+32.0%
0.00%0.0%
Q2 2020$230,000
+52.3%
9,085
+32.5%
0.00%0.0%
Q1 2020$151,0000.0%6,8550.0%0.00%0.0%
Q4 2019$151,0006,8550.00%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,355,392$29,859,0006.21%
Bain Capital Life Sciences Investors, LLC 3,080,237$67,858,0004.26%
DAFNA Capital Management LLC 587,756$12,948,0003.85%
SILVERARC CAPITAL MANAGEMENT, LLC 227,388$5,009,0002.91%
RTW INVESTMENTS, LP 7,253,857$159,802,0002.68%
Parkman Healthcare Partners LLC 331,513$7,303,0001.87%
Evolutionary Tree Capital Management, LLC 60,864$1,341,0001.02%
Eagle Health Investments LP 69,000$1,520,0000.97%
Woodline Partners LP 1,358,796$29,934,0000.79%
Affinity Asset Advisors, LLC 40,000$881,0000.47%
View complete list of DICERNA PHARMACEUTICALS INC shareholders